Interpace Diagnostics Group Stock News

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunomedics ( IMMU – Research Report ), Interpace Diagnostics Group ( IDXG – Research Report ) and

Gainers Dynavax (NASDAQ: DVAX) shares are trading higher after the company reported collaboration with Valneva to advance vaccine development for coronavirus. Sleep Number (...

Acquired Biopharma Business of Cancer Genetics in Second Half of 2019 Through Q1-2020 Raised $47 million from Two Top Private Equity FirmsProvides First Quarter 2020 Range of.

Some blood tests being marketed to tell people if they have had the new coronavirus are a "disaster", Roche Chief Executive Severin Schwan said on Wednesday as he prepares to launch the drugmaker's ow

Interpace (IDXG) announced today that it will release its financial results for the fourth quarter and full year 2019 this afternoon. Company management will host a conference call and webcast to dis

La croissance a été alimentée par la principale division Pharmaceuticals, dont les revenus ont progressé de 3% à 12,26 milliards. L'action a clôturé en nette hausse.

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rockwell Med (RMTI) and Motus Gi Holdings (MOTS) with

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rockwell Med ( RMTI – Research Report ) and Motus Gi Holdings ( MOTS – Research Report ) with bulli

Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com

Mar 18, 2020 (The Expresswire) -- Global “Hospital Acquired Infections (HAI) Diagnostics Market” Report 2020 is a comprehensive, professional report provides...

Interpace Diagnostics Group (NASDAQ:IDXG) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the s

Interpace Diagnostics, a subsidiary of Interpace Biosciences (IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts. While terms of this Agreement are

Interpace Diagnostics, a subsidiary of Interpace Biosciences (IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts with over 3 million members in Mass

The article, entitled “Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules”, will be published online in the coming weeks. The peer-

Interpace Biosciences, Inc. (IDXG) announced today that its agreement with LabCorp® (LH) has been extended for an additional two years, through January 2022. Interpace and LabCorp initially entered